Brief: Impel Neuropharma Announces Pricing Of $80.0 Million Initial Public Offering
April 22 (Reuters) - Impel Neuropharma Inc IMPL.O :
* IMPEL NEUROPHARMA ANNOUNCES PRICING OF $80.0 MILLION
INITIAL
PUBLIC OFFERING
* IMPEL NEUROPHARMA -PRICING OF ITS INITIAL PUBLIC OFFERING
OF 5.3
MILLION SHARES OF ITS COMMON STOCK AT A PRICE TO PUBLIC OF
$15.00 PER SHARE.
Source text for Eikon: ID:nGNXc3pQnm
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq